2022
DOI: 10.1002/jcph.2099
|View full text |Cite
|
Sign up to set email alerts
|

Risk Factors for Tigecycline‐Associated Hepatotoxicity in Patients in the Intensive Care Units of 2 Tertiary Hospitals: A Retrospective Study

Abstract: Tigecycline is a broad‐spectrum antibacterial agent. As the incidence of multidrug‐resistant bacterial infections has increased in intensive care units (ICUs) over the past decades, tigecycline is often used in ICUs. Information about tigecycline‐associated hepatotoxicity in ICU patients is limited. To investigate the potential risk factors for tigecycline‐associated hepatotoxicity in ICU patients, 148 patients from 2 centers who had received tigecycline for at least 4 days were retrospectively analyzed. Hepat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 20 publications
0
1
0
1
Order By: Relevance
“…[23]. В 2021 г. был описан случай клинически значимого острого повреждения печени при введении меропенема: через 3 сут после начала антибиотикотерапии у пациентки развилось смешанное гепатоцеллюлярное и холестатическое поражение печени с желтухой Гепатотоксические свойства тигециклина подтверждены в исследованиях in vitro, однако механизм поражения клеток печени не уточнен [37].…”
Section: материалы и методыunclassified
“…[23]. В 2021 г. был описан случай клинически значимого острого повреждения печени при введении меропенема: через 3 сут после начала антибиотикотерапии у пациентки развилось смешанное гепатоцеллюлярное и холестатическое поражение печени с желтухой Гепатотоксические свойства тигециклина подтверждены в исследованиях in vitro, однако механизм поражения клеток печени не уточнен [37].…”
Section: материалы и методыunclassified
“…Previous authors have utilized this system to grade the severity of AEs related to SMT 5,[32][33][34] . CTCAE is becoming a standard measurement system and is used in other fields, such as cancer therapies 35 , pharmacology 36 , and surgery 37 .…”
mentioning
confidence: 99%